{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:01:53Z","timestamp":1790370113615,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,8]],"date-time":"2017-04-08T00:00:00Z","timestamp":1491609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","journals.elsevierhealth.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.neo.2017.05.003","type":"journal-article","created":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T08:56:27Z","timestamp":1499763387000},"page":"637-648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Combined Inhibition of CDK4\/6 and PI3K\/AKT\/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells"],"prefix":"10.1016","volume":"19","author":[{"given":"Mara A.","family":"Bonelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziana","family":"Digiacomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Fumarola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Alfieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Quaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Falco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Madeddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"La Monica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Cretella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ravelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Ulivi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Tebaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Calistri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Delmonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Ampollini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Carbognani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Tiseo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cavazzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Giorgio","family":"Petronini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2017.05.003_bb0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-3-642-10862-4_2","article-title":"Epidemiology of mesothelioma and historical background","volume":"189","author":"Craighead","year":"2011","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.neo.2017.05.003_bb0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bcp.2016.07.012","article-title":"New therapeutic strategies for malignant pleural mesothelioma","volume":"123","author":"Bonelli","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neo.2017.05.003_bb0015","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/carcin\/bgt166","article-title":"Molecular pathogenesis of malignant mesothelioma","volume":"34","author":"Sekido","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.neo.2017.05.003_bb0020","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.jtho.2016.05.020","article-title":"The Genetic Landscape of Malignant Pleural Mesothelioma: Results from Massively Parallel Sequencing","volume":"11","author":"Hylebos","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.neo.2017.05.003_bb0025","first-page":"F115","article-title":"The p16INK4a\/CDKN2A tumor suppressor and its relatives","volume":"1378","author":"Ruas","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.neo.2017.05.003_bb0030","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.molcel.2016.04.023","article-title":"Inhibition of Rb Phosphorylation Leads to mTORC2-Mediated Activation of Akt","volume":"62","author":"Zhang","year":"2016","journal-title":"Mol Cell"},{"key":"10.1016\/j.neo.2017.05.003_bb0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ceb.2009.10.007","article-title":"mTOR and cancer: many loops in one pathway","volume":"22","author":"Efeyan","year":"2010","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.neo.2017.05.003_bb0040","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1158\/1535-7163.MCT-08-0017","article-title":"Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase\/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity","volume":"7","author":"Maira","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.neo.2017.05.003_bb0045","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1016\/j.bmcl.2013.05.007","article-title":"Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation","volume":"23","author":"Furet","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.neo.2017.05.003_bb0050","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1158\/1535-7163.MCT-07-0477","article-title":"Dual mechanisms of action of the 5-benzylidene-hydantoin UPR1024 on lung cancer cell lines","volume":"7","author":"Cavazzoni","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.neo.2017.05.003_bb0055","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1476-4598-10-143","article-title":"Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell lines","volume":"10","author":"Alfieri","year":"2011","journal-title":"Mol Cancer"},{"key":"10.1016\/j.neo.2017.05.003_bb0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.canlet.2012.03.034","article-title":"Overcoming acquired resistance to letrozole by targeting the PI3K\/AKT\/mTOR pathway in breast cancer cell clones","volume":"323","author":"Cavazzoni","year":"2012","journal-title":"Cancer Lett"},{"key":"10.1016\/j.neo.2017.05.003_bb0065","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.tiv.2007.03.003","article-title":"A mathematical approach to study combined effects of toxicants in vitro: evaluation of the Bliss independence criterion and the Loewe additivity model","volume":"21","author":"Goldoni","year":"2007","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.neo.2017.05.003_bb0070","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/sj.cdd.4401660","article-title":"Cell size reduction induced by inhibition of the mTOR\/S6K-signaling pathway protects Jurkat cells from apoptosis","volume":"12","author":"Fumarola","year":"2005","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.neo.2017.05.003_bb0075","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jtho.2016.03.006","article-title":"Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation","volume":"11","author":"La Monica","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.neo.2017.05.003_bb0080","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1158\/1535-7163.MCT-14-0892","article-title":"Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations","volume":"14","author":"Bonelli","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.neo.2017.05.003_bb0085","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neo.2017.05.003_bb0090","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"10.1016\/j.neo.2017.05.003_bb0095","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nbt.2514","article-title":"Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples","volume":"31","author":"Cibulskis","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.neo.2017.05.003_bb0100","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.neo.2017.05.003_bb0105","doi-asserted-by":"crossref","first-page":"R77","DOI":"10.1186\/bcr2419","article-title":"PD 0332991, a selective cyclin D kinase 4\/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro","volume":"11","author":"Finn","year":"2009","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.neo.2017.05.003_bb0110","article-title":"Palbociclib (PD-0332991), a selective CDK4\/6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma","author":"Bollard","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.neo.2017.05.003_bb0115","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.1158\/1078-0432.CCR-13-1675","article-title":"Dual CDK4\/CDK6 inhibition induces cell-cycle arrest and senescence in neuroblastoma","volume":"19","author":"Rader","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.neo.2017.05.003_bb0120","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.4161\/cc.26130","article-title":"CDK4\/6-inhibiting drug substitutes for p21 and p16 in senescence: duration of cell cycle arrest and MTOR activity determine geroconversion","volume":"12","author":"Leontieva","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.neo.2017.05.003_bb0125","doi-asserted-by":"crossref","first-page":"8226","DOI":"10.18632\/oncotarget.3364","article-title":"MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition","volume":"6","author":"Kovatcheva","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2017.05.003_bb0130","doi-asserted-by":"crossref","first-page":"11501","DOI":"10.1073\/pnas.1001613107","article-title":"Pattern of retinoblastoma pathway inactivation dictates response to CDK4\/6 inhibition in GBM","volume":"107","author":"Wiedemeyer","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neo.2017.05.003_bb0135","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1101\/gad.1033002","article-title":"Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf\/p53-independent senescence","volume":"16","author":"Zou","year":"2002","journal-title":"Genes Dev"},{"key":"10.1016\/j.neo.2017.05.003_bb0140","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.1158\/0008-5472.CAN-06-1098","article-title":"A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4\/6","volume":"66","author":"Baughn","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2017.05.003_bb0145","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.dnarep.2016.04.008","article-title":"Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage","volume":"42","author":"Karimian","year":"2016","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.neo.2017.05.003_bb0150","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/sj.onc.1206145","article-title":"Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter","volume":"22","author":"Wu","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2017.05.003_bb0155","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.1038\/onc.2008.258","article-title":"C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells","volume":"27","author":"Zhuang","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2017.05.003_bb0160","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/leu.2015.185","article-title":"Dual inhibition of CDK4\/Rb and PI3K\/AKT\/mTOR pathways by ON123300 induces synthetic lethality in mantle cell lymphomas","volume":"30","author":"Divakar","year":"2016","journal-title":"Leukemia"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558617301537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558617301537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T10:23:17Z","timestamp":1535624597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558617301537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1476558617301537"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2017.05.003","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined Inhibition of CDK4\/6 and PI3K\/AKT\/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2017.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc. on behalf of Neoplasia Press, Inc.","name":"copyright","label":"Copyright"}]}}